Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]

View source ↗

Summary

Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Hepatitis B
• Invasive Haemophilus Influenzae Type Disease
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTaP-IPV-Hep B-PRP~T Combined Vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2015-09-25